Literature DB >> 2182735

Lymphopoiesis and IL-7.

M B Widmer1, P J Morrissey, R G Goodwin, K H Grabstein, L S Park, J D Watson, P W Kincade, P J Conlon, A E Namen.   

Abstract

Interleukin 7 (IL-7) is a cytokine initially referred to as pre-B cell growth factor because of its growth-promoting activity for cells early in the B lymphocyte lineage. Subsequent to IL-7 gene cloning and expression, IL-7 was also found to influence the activity of cells in the T lineage. Some of the effects of IL-7 on B and T lymphocyte behavior, both in vitro and in vivo, are discussed here. The growth of pre-B cells in Whitlock-Witte long-term bone marrow cultures [1] provided the basis for the cloning of IL-7 [2]. Such cultures consist of at least two cellular elements: 1) a stromal cell layer and 2) lymphoid cells growing in clusters around the stromal cells. A cDNA encoding IL-7 was cloned utilizing a direct expression cloning strategy. A transformed stromal cell line was used as a source of RNA from which a cDNA library was constructed, inserted into a mammalian expression vector and expressed in COS 7 cells. The COS cells were then screened for secretion of IL-7 into the culture medium as defined by the ability to support stromal cell-independent growth of the lymphoid elements from long-term Whitlock-Witte cultures. In addition to its effects on cells from long-term marrow cultures, IL-7 stimulates growth of cells in cultures of fresh bone marrow [3]. Cells from whole bone marrow plated in semisolid agar form colonies in the presence of IL-7. If the marrow is first enriched for cells expressing the B220 antigen before culture in IL-7, the plating efficiency is increased dramatically.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2182735     DOI: 10.1002/stem.5530080715

Source DB:  PubMed          Journal:  Int J Cell Cloning        ISSN: 0737-1454


  3 in total

1.  Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray.

Authors:  Daniel S Chen; Yoav Soen; Tor B Stuge; Peter P Lee; Jeffrey S Weber; Patrick O Brown; Mark M Davis
Journal:  PLoS Med       Date:  2005-09-20       Impact factor: 11.069

2.  Impairment of T and B cell development by treatment with a type I interferon.

Authors:  Q Lin; C Dong; M D Cooper
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

3.  Nonviral production of human interleukin-7 in spodoptera frugiperda insect cells as a soluble recombinant protein.

Authors:  Maryam Mirzaei; Yan Xu; Cynthia B Elias; Satya Prakash
Journal:  J Biomed Biotechnol       Date:  2008-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.